Marijuana Moment reports
Indiana’s Senate Health and Provider Services Committee on Wednesday unanimously approved a bill that would fund clinical research trials into psilocybin, making two relatively minor amendments before advancing the legislation.
“There’s reason to believe that there is value in psilocybin and, at this point, I want to elevate the discussion,” said Sen. Ed Charbonneau (R), the bill’s sponsor and committee chair. “We need to be taking a look at something like this that is so important to our veterans with PTSD and many other issues.”
Charbonneau emphasized that the bill does not change the legal status of psilocybin under Indiana law. Instead it seeks to propel research into the substance, which the federal government has granted breakthrough-therapy status.